Income Statement GE HealthCare Technologies Inc.

Equities

GEHC

US36266G1076

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Other stock markets 04:00:00 2025-12-12 pm EST			5-day change	1st Jan Change
83.96 ^USD	-2.43%		-1.76%	+7.39%

Dec. 12	Wells Fargo Adjusts PT on GE Healthcare Technologies to $95 From $87, Maintains Overweight Rating	MT
Dec. 12	JPMorgan Adjusts PT on GE Healthcare Technologies to $80 From $78, Maintains Neutral Rating	MT

31928f6cc690d86fc13d.MyT6mfd3aPZp0TNXeY6znizK_aYF79UQ8z0BRgdVRE4.aU7I_ccVWbkCmAc6M9rhzkG9y_dXoINUt1NTBzUtcQUGXY_whz9YtwSkVA

Published financial data: GE HEALTHCARE TECHNOLOGIES INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	17.16B	17.58B	18.34B	19.55B	19.67B
Total Revenues	17.16B	17.58B	18.34B	19.55B	19.67B
Cost of Goods Sold, Total	10.4B	10.41B	11.16B	11.63B	11.47B
Gross Profit	6.77B	7.17B	7.18B	7.92B	8.2B
Selling General & Admin Expenses, Total	3.24B	3.56B	3.62B	3.91B	3.87B
R&D Expenses	810M	816M	1.03B	1.2B	1.31B
Other Operating Expenses, Total	4.05B	4.38B	4.65B	5.11B	5.18B
Operating Income	2.72B	2.79B	2.53B	2.81B	3.03B
Interest Expense, Total	-66M	-40M	-86M	-505M	-463M
Interest And Investment Income	49M	34M	-	26M	-
Net Interest Expenses	-17M	-6M	-86M	-479M	-463M
Income (Loss) On Equity Invest.	7M	27M	13M	11M	8M
Currency Exchange Gains (Loss)	-	-	-	-37M	-42M
Other Non Operating Income (Expenses)	4M	60M	53M	38M	34M
EBT, Excl. Unusual Items	2.71B	2.88B	2.51B	2.34B	2.56B
Other Unusual Items	-	-	-	17M	18M
EBT, Incl. Unusual Items	2.71B	2.88B	2.51B	2.36B	2.58B
Income Tax Expense	652M	600M	563M	743M	531M
Earnings From Continuing Operations	2.06B	2.28B	1.95B	1.62B	2.05B
Earnings Of Discontinued Operations	11.84B	18M	18M	-4M	-
Net Income to Company	13.9B	2.29B	1.97B	1.61B	2.05B
Minority Interest	-51M	-46M	-51M	-229M	-57M
Net Income - (IS)	13.85B	2.25B	1.92B	1.38B	1.99B
Net Income to Common Incl Extra Items	13.85B	2.25B	1.92B	1.38B	1.99B
Net Income to Common Excl. Extra Items	2.01B	2.23B	1.9B	1.39B	1.99B
Per Share Items
Net EPS - Basic	-	-	-	3.04	4.37
Basic EPS - Continuing Operations	-	-	-	3.05	4.37
Basic Weighted Average Shares Outstanding	-	-	-	455M	456M
Net EPS - Diluted	-	-	-	3.03	4.34
Diluted EPS - Continuing Operations	-	-	-	3.04	4.34
Diluted Weighted Average Shares Outstanding	-	-	-	458M	459M
Normalized Basic EPS	-	-	-	2.72	3.39
Normalized Diluted EPS	-	-	-	2.7	3.37
Dividend Per Share	-	-	-	0.12	0.12
Payout Ratio	-	-	-	2.96	2.76
Supplemental Items
EBITDA	3.35B	3.42B	3.16B	3.42B	3.61B
EBITA	3.12B	3.19B	2.94B	3.17B	3.34B
EBIT	2.72B	2.79B	2.53B	2.81B	3.03B
EBITDAR	3.55B	3.6B	3.38B	3.65B	3.86B
Total Revenues (As Reported)	17.16B	17.58B	18.34B	19.55B	19.67B
Effective Tax Rate - (Ratio)	24.06	20.87	22.41	31.47	20.57
Current Domestic Taxes	315M	196M	493M	213M	70M
Current Foreign Taxes	463M	422M	324M	345M	412M
Total Current Taxes	778M	618M	817M	558M	482M
Deferred Domestic Taxes	3M	83M	-261M	82M	61M
Deferred Foreign Taxes	-129M	-101M	7M	103M	-12M
Total Deferred Taxes	-126M	-18M	-254M	185M	49M
Normalized Net Income	1.64B	1.75B	1.52B	1.24B	1.54B
Interest on Long-Term Debt	-	-	-	616M	580M
Non-Cash Pension Expense	4M	1M	-10M	-301M	-325M
Supplemental Operating Expense Items
Research And Development Expense From Footnotes	810M	816M	1.03B	1.2B	1.31B
Net Rental Expense, Total	201M	185M	217M	229M	258M
Imputed Operating Lease Interest Expense	-	1.64B	32.91M	100M	99.34M
Imputed Operating Lease Depreciation	-	-1.46B	184M	129M	159M
Stock-Based Comp., Other (Total)	-	-	-	114M	125M
Total Stock-Based Compensation	-	-	-	114M	125M

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	1.01B	556M	1.44B	2.49B	2.87B
Total Cash And Short Term Investments	1.01B	556M	1.44B	2.49B	2.87B
Accounts Receivable, Total	2.36B	3.66B	3.6B	3.84B	3.87B
Other Receivables	-	-	291M	316M	406M
Notes Receivable	125M	99M	97M	97M	90M
Total Receivables	2.48B	3.76B	3.99B	4.25B	4.36B
Inventory	1.59B	1.95B	2.16B	1.96B	1.94B
Prepaid Expenses	144M	163M	163M	147M	188M
Restricted Cash	-	-	5M	10M	16M
Other Current Assets, Total	671M	576M	562M	545M	522M
Total Current Assets	5.9B	7B	8.32B	9.41B	9.9B
Gross Property Plant And Equipment	4.89B	5.05B	5.3B	5.56B	5.63B
Accumulated Depreciation	-2.69B	-2.82B	-2.99B	-3.06B	-3.08B
Net Property Plant And Equipment	2.2B	2.24B	2.31B	2.5B	2.55B
Long-term Investments	344M	341M	322M	357M	373M
Goodwill	11.87B	12.89B	12.81B	12.94B	13.14B
Other Intangibles, Total	1.6B	1.85B	1.52B	1.25B	1.08B
Accounts Receivable Long-Term	15M	19M	86M	168M	208M
Loans Receivable Long-Term	230M	186M	196M	178M	183M
Deferred Tax Assets Long-Term	1.49B	1.29B	1.55B	4.47B	4.47B
Deferred Charges Long-Term	71M	77M	82M	-	-
Other Long-Term Assets, Total	510M	424M	338M	1.18B	1.19B
Total Assets	24.23B	26.31B	27.54B	32.45B	33.09B
Liabilities
Accounts Payable, Total	2.16B	2.54B	2.94B	2.95B	3.02B
Accrued Expenses, Total	-	-	1.33B	1.99B	2.04B
Short-term Borrowings	-	-	-	1.01B	2M
Current Portion of Long-Term Debt	4M	6M	15M	-	1.5B
Current Portion of Leases	-	-	104M	110M	115M
Current Income Taxes Payable	-	-	-	-	279M
Unearned Revenue Current, Total	1.81B	1.86B	1.9B	1.92B	1.94B
Other Current Liabilities	2.54B	2.35B	899M	1.01B	657M
Total Current Liabilities	6.52B	6.76B	7.19B	8.98B	9.55B
Long-Term Debt	31M	31M	8.23B	8.44B	7.45B
Long-Term Leases	-	-	282M	311M	310M
Unearned Revenue Non Current	-	-	630M	705M	687M
Pension & Other Post Retirement Benefits	805M	751M	549M	5.78B	5.58B
Deferred Tax Liability Non Current	459M	385M	370M	68M	56M
Other Non Current Liabilities	1.44B	1.48B	691M	861M	799M
Total Liabilities	9.25B	9.41B	17.95B	25.14B	24.44B
Common Stock, Total	15.57B	17.69B	11.24B	5M	5M
Additional Paid In Capital	-	-	-	6.49B	6.58B
Retained Earnings	-	-	-	1.33B	3.26B
Treasury Stock	-	-	-	-	-25M
Comprehensive Income and Other	-839M	-1.04B	-1.88B	-691M	-1.38B
Total Common Equity	14.73B	16.66B	9.36B	7.13B	8.45B
Minority Interest	247M	241M	235M	177M	206M
Total Equity	14.97B	16.9B	9.59B	7.31B	8.65B
Total Liabilities And Equity	24.23B	26.31B	27.54B	32.45B	33.09B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	-	-	454M	455M	457M
ECS Total Common Shares Outstanding	-	-	-	455M	457M
Book Value / Share	-	-	-	15.67	18.48
Tangible Book Value	1.26B	1.92B	-4.98B	-7.06B	-5.77B
Tangible Book Value Per Share	-	-	-	-15.5	-12.62
Total Debt	35M	37M	8.64B	9.86B	9.38B
Net Debt	-972M	-519M	7.2B	7.37B	6.5B
Debt Equivalent of Unfunded Proj. Benefit Obligation	511M	387M	278M	3.53B	3.54B
Debt Equivalent Oper. Leases	1.61B	1.48B	1.74B	1.83B	2.06B
Minority Interest, Total (Incl. Fin. Div)	247M	241M	235M	177M	206M
Equity Method Investments, Total	344M	341M	322M	357M	373M
Account Code - Inventory Valuation	-	5	5	5	5
Inventories - Raw Materials, Total	726M	900M	1.05B	961M	921M
Inventories - Work In Process, Total	62M	104M	91M	91M	92M
Inventories - Finished Goods, Total	806M	942M	1.01B	908M	926M
Land - (BS)	70M	77M	70M	70M	66M
Buildings, Total	1.74B	1.76B	1.89B	1.96B	1.94B
Machinery, Total	2.35B	2.47B	2.54B	2.62B	2.7B
Full Time Employees	-	51K	50K	51K	53K
Accumulated Allowance for Doubtful Accounts (Supple)	93M	107M	91M	98M	103M

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	13.85B	2.25B	1.92B	1.38B	1.99B
Depreciation & Amortization - CF	222M	225M	228M	248M	268M
Amortization of Goodwill and Intangible Assets - (CF)	408M	400M	405M	362M	312M
Depreciation & Amortization, Total	630M	625M	633M	610M	580M
Stock-Based Compensation (CF)	-	-	-	114M	125M
Net Cash From Discontinued Operations	-931M	-	-21M	-	-4M
Other Operating Activities, Total	-11.94B	13M	-320M	-204M	-610M
Change In Accounts Receivable	-278M	-1.31B	-453M	-175M	-175M
Change In Inventories	100M	-435M	-402M	111M	-81M
Change In Accounts Payable	-113M	263M	481M	-13M	126M
Change in Unearned Revenues	312M	-21M	138M	26M	68M
Change in Other Net Operating Assets	66M	228M	141M	247M	-71M
Cash from Operations	1.69B	1.61B	2.11B	2.1B	1.95B
Capital Expenditure	-237M	-242M	-310M	-387M	-401M
Sale of Property, Plant, and Equipment	16M	15M	4M	1M	-
Cash Acquisitions	-78M	-1.48B	-	-147M	-313M
Sale (Purchase) of Intangible assets	-22M	-6M	-	-	-
Investment in Marketable and Equity Securities, Total	-	-	-	-	-40M
Other Investing Activities, Total	20.31B	-47M	-92M	-25M	-160M
Cash from Investing	19.99B	-1.76B	-398M	-558M	-914M
Short Term Debt Issued, Total	-	-	9M	-	-
Long-Term Debt Issued, Total	4M	5M	8.2B	2.01B	995M
Total Debt Issued	4M	5M	8.21B	2.01B	995M
Short Term Debt Repaid, Total	-10M	-7M	-	-12M	-
Long-Term Debt Repaid, Total	-10M	-10M	-3M	-855M	-1.42B
Total Debt Repaid	-20M	-17M	-3M	-867M	-1.42B
Issuance of Common Stock	-	-	-	-	33M
Repurchase of Common Stock	-	-	-	-	-93M
Common Dividends Paid	-	-	-	-41M	-55M
Common & Preferred Stock Dividends Paid	-	-	-	-41M	-55M
Other Financing Activities, Total	-21.53B	-251M	-9.03B	-1.58B	-35M
Cash from Financing	-21.54B	-263M	-822M	-478M	-573M
Foreign Exchange Rate Adjustments	14M	-34M	-3M	-10M	-77M
Net Change in Cash	143M	-451M	890M	1.06B	387M
Supplemental Items
Cash Interest Paid	46M	21M	-	570M	550M
Cash Income Tax Paid (Refund)	-	-	-	474M	491M
Levered Free Cash Flow	-	778M	1.84B	2.53B	1.86B
Unlevered Free Cash Flow	-	803M	1.89B	2.85B	2.15B
Change In Net Working Capital	-	1.32B	11M	-755M	41M
Net Debt Issued / Repaid	-16M	-12M	8.2B	1.14B	-423M

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	-	6.91	5.88	5.86	5.77
Return on Total Capital	-	10.93	8.9	9.93	10.75
Return On Equity %	-	14.28	14.72	19.15	25.69
Return on Common Equity	-	14.21	14.59	16.85	25.59
Margin Analysis
Gross Profit Margin %	39.43	40.8	39.14	40.52	41.71
SG&A Margin	18.88	20.27	19.74	19.98	19.66
EBITDA Margin %	19.49	19.44	17.26	17.5	18.33
EBITA Margin %	18.2	18.16	16.01	16.23	16.97
EBIT Margin %	15.82	15.89	13.81	14.38	15.38
Income From Continuing Operations Margin %	11.99	12.94	10.63	8.28	10.42
Net Income Margin %	80.67	12.78	10.45	7.08	10.13
Net Avail. For Common Margin %	11.69	12.68	10.35	7.1	10.13
Normalized Net Income Margin	9.57	9.96	8.28	6.32	7.85
Levered Free Cash Flow Margin	-	4.43	10.04	12.96	9.48
Unlevered Free Cash Flow Margin	-	4.57	10.33	14.57	10.95
Asset Turnover
Asset Turnover	-	0.7	0.68	0.65	0.6
Fixed Assets Turnover	-	7.93	8.06	8.12	7.79
Receivables Turnover (Average Receivables)	-	5.85	5.27	5.25	5.1
Inventory Turnover (Average Inventory)	-	5.88	5.44	5.65	5.88
Short Term Liquidity
Current Ratio	0.9	1.04	1.16	1.05	1.04
Quick Ratio	0.52	0.62	0.74	0.74	0.75
Operating Cash Flow to Current Liabilities	0.26	0.24	0.29	0.23	0.2
Days Sales Outstanding (Average Receivables)	-	62.42	69.24	69.5	71.7
Days Outstanding Inventory (Average Inventory)	-	62.05	67.05	64.57	62.22
Average Days Payable Outstanding	-	79.73	88.02	94.02	95.43
Cash Conversion Cycle (Average Days)	-	44.75	48.28	40.06	38.49
Long Term Solvency
Total Debt/Equity	0.23	0.22	90.02	134.92	108.37
Total Debt / Total Capital	0.23	0.22	47.37	57.43	52.01
LT Debt/Equity	0.21	0.18	88.78	119.66	89.68
Long-Term Debt / Total Capital	0.21	0.18	46.72	50.93	43.04
Total Liabilities / Total Assets	38.2	35.78	65.17	77.48	73.85
EBIT / Interest Expense	41.15	69.85	29.44	5.57	6.54
EBITDA / Interest Expense	50.7	85.48	39.33	7.23	8.35
(EBITDA - Capex) / Interest Expense	47.11	79.42	35.72	6.46	7.48
Total Debt / EBITDA	0.01	0.01	2.55	2.7	2.43
Net Debt / EBITDA	-0.29	-0.15	2.13	2.02	1.68
Total Debt / (EBITDA - Capex)	0.01	0.01	2.81	3.02	2.71
Net Debt / (EBITDA - Capex)	-0.31	-0.16	2.34	2.26	1.88
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	3.19	2.45	4.3	6.6	0.61
Gross Profit, 1 Yr. Growth %	3.34	6.01	0.07	10.35	3.57
EBITDA, 1 Yr. Growth %	20.58	2.18	-7.43	10.35	5.41
EBITA, 1 Yr. Growth %	22.51	2.24	-8.05	10.48	5.2
EBIT, 1 Yr. Growth %	28.36	2.87	-9.38	13.94	7.65
Earnings From Cont. Operations, 1 Yr. Growth %	22.43	10.54	-14.33	-16.98	26.7
Net Income, 1 Yr. Growth %	808.53	-83.77	-14.73	-27.71	43.9
Normalized Net Income, 1 Yr. Growth %	28.55	6.58	-13.24	-16.39	24.99
Diluted EPS Before Extra, 1 Yr. Growth %	-	-	-	-27.27	42.76
Accounts Receivable, 1 Yr. Growth %	-	55.41	7.48	6.55	0.68
Inventory, 1 Yr. Growth %	-	22.08	10.74	-9.05	-1.07
Net Property, Plant and Equip., 1 Yr. Growth %	-	1.5	3.53	8.04	2
Total Assets, 1 Yr. Growth %	-	8.59	4.68	17.85	1.96
Tangible Book Value, 1 Yr. Growth %	-	52.55	-359.71	41.8	-18.25
Common Equity, 1 Yr. Growth %	-	13.09	-43.82	-23.77	18.41
Cash From Operations, 1 Yr. Growth %	-15.18	-4.74	31.49	-0.57	-7.14
Capital Expenditures, 1 Yr. Growth %	-9.89	2.11	28.1	24.84	3.62
Levered Free Cash Flow, 1 Yr. Growth %	-	-	173.82	35.68	-26.38
Unlevered Free Cash Flow, 1 Yr. Growth %	-	-	171.71	48.31	-24.38
Dividend Per Share, 1 Yr. Growth %	-	-	-	-	4.17
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-	2.82	3.37	5.44	3.56
Gross Profit, 2 Yr. CAGR %	-	4.67	3	5.08	6.91
EBITDA, 2 Yr. CAGR %	-	11	-2.74	0.03	7.85
EBITA, 2 Yr. CAGR %	-	11.92	-3.04	-0.33	7.81
EBIT, 2 Yr. CAGR %	-	14.91	-3.45	0.3	10.75
Earnings From Cont. Operations, 2 Yr. CAGR %	-	16.33	-2.68	-15.67	2.56
Net Income, 2 Yr. CAGR %	-	21.43	-62.8	-21.49	1.99
Normalized Net Income, 2 Yr. CAGR %	-	17.05	-3.84	-15.98	2.22
Diluted EPS Before Extra, 2 Yr. CAGR %	-	-	-	-21.31	1.9
Accounts Receivable, 2 Yr. CAGR %	-	-	23.72	7.01	3.57
Inventory, 2 Yr. CAGR %	-	-	16.27	0.36	-5.14
Net Property, Plant and Equip., 2 Yr. CAGR %	-	-	2.51	5.76	4.98
Total Assets, 2 Yr. CAGR %	-	-	6.61	11.07	9.61
Tangible Book Value, 2 Yr. CAGR %	-	-	99.04	91.9	7.66
Common Equity, 2 Yr. CAGR %	-	-	-20.29	-34.56	-4.99
Cash From Operations, 2 Yr. CAGR %	-	-10.11	11.92	14.34	-3.91
Capital Expenditures, 2 Yr. CAGR %	-	-4.08	14.37	24.92	13.73
Levered Free Cash Flow, 2 Yr. CAGR %	-	-	-	84	-0.06
Unlevered Free Cash Flow, 2 Yr. CAGR %	-	-	-	91.94	5.9
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-	-	3.31	4.44	3.81
Gross Profit, 3 Yr. CAGR %	-	-	3.11	5.39	4.58
EBITDA, 3 Yr. CAGR %	-	-	4.48	0.74	1.79
EBITA, 3 Yr. CAGR %	-	-	4.82	0.52	1.48
EBIT, 3 Yr. CAGR %	-	-	6.17	1.15	2.69
Earnings From Cont. Operations, 3 Yr. CAGR %	-	-	5.05	-7.71	-3.41
Net Income, 3 Yr. CAGR %	-	-	7.93	-53.58	-3.92
Normalized Net Income, 3 Yr. CAGR %	-	-	5.93	-9.05	-4.09
Diluted EPS Before Extra, 3 Yr. CAGR %	-	-	-	-	-4.03
Accounts Receivable, 3 Yr. CAGR %	-	-	-	17.71	4.86
Inventory, 3 Yr. CAGR %	-	-	-	7.13	-0.12
Net Property, Plant and Equip., 3 Yr. CAGR %	-	-	-	4.32	4.49
Total Assets, 3 Yr. CAGR %	-	-	-	10.23	7.94
Tangible Book Value, 3 Yr. CAGR %	-	-	-	77.77	44.39
Common Equity, 3 Yr. CAGR %	-	-	-	-21.47	-20.26
Cash From Operations, 3 Yr. CAGR %	-	-	2.04	7.59	6.68
Capital Expenditures, 3 Yr. CAGR %	-	-	5.63	17.76	17.37
Levered Free Cash Flow, 3 Yr. CAGR %	-	-	-	-	35.58
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	-	-	-	40.71
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-	-	-	-	3.41
Gross Profit, 5 Yr. CAGR %	-	-	-	-	4.62
EBITDA, 5 Yr. CAGR %	-	-	-	-	5.38
EBITA, 5 Yr. CAGR %	-	-	-	-	5.53
EBIT, 5 Yr. CAGR %	-	-	-	-	7.42
Earnings From Cont. Operations, 5 Yr. CAGR %	-	-	-	-	4.05
Net Income, 5 Yr. CAGR %	-	-	-	-	5.51
Normalized Net Income, 5 Yr. CAGR %	-	-	-	-	3.87
Cash From Operations, 5 Yr. CAGR %	-	-	-	-	-0.39
Capital Expenditures, 5 Yr. CAGR %	-	-	-	-	8.8